METHOD OF TREATMENT OF PULMONARY COMPLICATIONS IN PATIENTS WITH SERIOUS CRANIOCEREBRAL INJURY

FIELD: medicine, particularly, intensive therapy. SUBSTANCE: method includes, in acute period, hemofiltration against background of T-activin endotracheal inhalation for 10 min with interval of 3 h, during 7-12 days. As a result, actively removed from blood are biologically active substance with mea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RODIONOV E.P, KRAVTSOV S.A
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RODIONOV E.P
KRAVTSOV S.A
description FIELD: medicine, particularly, intensive therapy. SUBSTANCE: method includes, in acute period, hemofiltration against background of T-activin endotracheal inhalation for 10 min with interval of 3 h, during 7-12 days. As a result, actively removed from blood are biologically active substance with mean molecular weight; with no development of immunodeficiency that reduces frequency of development of pulmonary complications. EFFECT: higher efficiency of treatment.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2141831C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2141831C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2141831C13</originalsourceid><addsrcrecordid>eNqNykEKwjAQheFsXIh6h7mAi1gXbmOc0kiTCZMJ0oWUInElWqj3xwoewNX7H3xLdfUoDZ2AahBGIx6DfE_MradguANLPrbOGnEUErgAcc5ZJbg4aSAhO8oJLJvgyCLjkU07u3Pmbq0W9-Exlc1vVwpqFNtsy_jqyzQOt_Is757zTu_1odJWV3-QD8isMtk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD OF TREATMENT OF PULMONARY COMPLICATIONS IN PATIENTS WITH SERIOUS CRANIOCEREBRAL INJURY</title><source>esp@cenet</source><creator>RODIONOV E.P ; KRAVTSOV S.A</creator><creatorcontrib>RODIONOV E.P ; KRAVTSOV S.A</creatorcontrib><description>FIELD: medicine, particularly, intensive therapy. SUBSTANCE: method includes, in acute period, hemofiltration against background of T-activin endotracheal inhalation for 10 min with interval of 3 h, during 7-12 days. As a result, actively removed from blood are biologically active substance with mean molecular weight; with no development of immunodeficiency that reduces frequency of development of pulmonary complications. EFFECT: higher efficiency of treatment.</description><edition>6</edition><language>eng</language><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19991127&amp;DB=EPODOC&amp;CC=RU&amp;NR=2141831C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19991127&amp;DB=EPODOC&amp;CC=RU&amp;NR=2141831C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RODIONOV E.P</creatorcontrib><creatorcontrib>KRAVTSOV S.A</creatorcontrib><title>METHOD OF TREATMENT OF PULMONARY COMPLICATIONS IN PATIENTS WITH SERIOUS CRANIOCEREBRAL INJURY</title><description>FIELD: medicine, particularly, intensive therapy. SUBSTANCE: method includes, in acute period, hemofiltration against background of T-activin endotracheal inhalation for 10 min with interval of 3 h, during 7-12 days. As a result, actively removed from blood are biologically active substance with mean molecular weight; with no development of immunodeficiency that reduces frequency of development of pulmonary complications. EFFECT: higher efficiency of treatment.</description><subject>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</subject><subject>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</subject><subject>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNykEKwjAQheFsXIh6h7mAi1gXbmOc0kiTCZMJ0oWUInElWqj3xwoewNX7H3xLdfUoDZ2AahBGIx6DfE_MradguANLPrbOGnEUErgAcc5ZJbg4aSAhO8oJLJvgyCLjkU07u3Pmbq0W9-Exlc1vVwpqFNtsy_jqyzQOt_Is757zTu_1odJWV3-QD8isMtk</recordid><startdate>19991127</startdate><enddate>19991127</enddate><creator>RODIONOV E.P</creator><creator>KRAVTSOV S.A</creator><scope>EVB</scope></search><sort><creationdate>19991127</creationdate><title>METHOD OF TREATMENT OF PULMONARY COMPLICATIONS IN PATIENTS WITH SERIOUS CRANIOCEREBRAL INJURY</title><author>RODIONOV E.P ; KRAVTSOV S.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2141831C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY</topic><topic>DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR</topic><topic>DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>RODIONOV E.P</creatorcontrib><creatorcontrib>KRAVTSOV S.A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RODIONOV E.P</au><au>KRAVTSOV S.A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD OF TREATMENT OF PULMONARY COMPLICATIONS IN PATIENTS WITH SERIOUS CRANIOCEREBRAL INJURY</title><date>1999-11-27</date><risdate>1999</risdate><abstract>FIELD: medicine, particularly, intensive therapy. SUBSTANCE: method includes, in acute period, hemofiltration against background of T-activin endotracheal inhalation for 10 min with interval of 3 h, during 7-12 days. As a result, actively removed from blood are biologically active substance with mean molecular weight; with no development of immunodeficiency that reduces frequency of development of pulmonary complications. EFFECT: higher efficiency of treatment.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_RU2141831C1
source esp@cenet
subjects DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title METHOD OF TREATMENT OF PULMONARY COMPLICATIONS IN PATIENTS WITH SERIOUS CRANIOCEREBRAL INJURY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A38%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RODIONOV%20E.P&rft.date=1999-11-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2141831C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true